Pure Biologics is at the forefront of developing innovative biological drugs, focusing on antibody and aptamer technologies to create new therapeutic options, particularly in the fields of immuno-oncology and non-systemic treatments for various diseases. The company has made significant strides with its lead projects, PB004 and PB003G, which are advancing towards Phase 0 clinical trials. These projects aim to address hematological malignancies and solid tumors, with promising in vivo results indicating their potential efficacy and safety. Pure Biologics is committed to a "Smart IO" approach, which emphasizes the development of drug candidates with comprehensive mechanisms of action that could offer competitive advantages over existing therapies.

In addition to its therapeutic development, Pure Biologics is also focused on creating biomolecular filters utilizing active aptamers for non-systemic therapies, which can effectively capture pathogens from the blood. The company is actively engaged in collaborative projects with both Polish and international research units, enhancing its scientific partnerships and positioning within the biopharmaceutical sector. By leveraging its technology platforms, Pure Biologics aims to independently manage all phases of drug discovery and development, while also planning to expand its portfolio to include five drug projects by the end of 2024. The company is also re-establishing its service business to generate additional revenue, focusing on the selection and characterization of active molecules for medical applications.

Poland

Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers.
Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterisation of antibodies and aptamers, as well as protein production, purification and analysis.

Pure Biologics

Company Details